Team:Cairo Egypt/Team

Instructors
Students

Dr. Maged Ghoneima

Maged Ghoneima received his B.Sc. (with honors) degree in electronics and communications engineering and M.Sc. degree in electronics from Ain Shams University, Cairo, Egypt, in 1997 and 2000 respectively. He received his Ph.D. degree in computer engineering from Northwestern University, Evanston, IL, in 2006. During 2002 he was with OEA International. Between 2003 and 2005 he was with the Circuit Research Laboratory, Intel Corporation. He also worked in Nvidia Corporation from 2006, as a Senior Circuit Design Engineer, developing on-chip memory structures for the Tesla and Fermi graphics processing units (GPUs). Dr. Ghoneima is an assistant professor research professor in the Mechatronics Department. He is the author/coauthor of more than 40 technical papers published in refereed international conferences and journals. He holds three granted patents in the area of low-power and high-performance circuit design.

Dr. Mohamed Zaazoue

Dr. Mohamed Zaazoue is a 26 year old neurosurgery resident in Egypt and the founding President of an Egyptian-based NGO called "Healthy Egyptians". He has become an Ashoka fellow, the youngest fellow worldwide in the field of health, and has been recognized byForbes as one of the most influential people under the age of 30 in the field of social entrepreneurship in their “30 under 30” list of 2014. Zaazoue has been awarded and featured in a report in the Financial Times in their “Urban Ingenuity Award”

Dr. Salwa Sabet

Associate Professor of Molecular Biology, Faculty of Science, Cairo University, Cairo,
Dr. Sabet research interest is studying the most prevalent diseases in Egypt as Cancer and Hepatitis C Virus. Regarding cancer, Dr. Sabet is interested in studying genetic alterations associated with cancer disease, including epigenetic changes, polymorphism and their contribution in disease progression, which might help in cancer diagnosis and drug development. Dr. Sabet is also interested in studying the expression and structure of different proteins of HCV4a in order to determine their active sites for drug development.